6133 — Vital Innovations Holdings Balance Sheet
0.000.00%
Last trade - 00:00- HK$134.30m
- HK$144.60m
- CNY835.61m
Annual balance sheet for Vital Innovations Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 51.2 | 54.4 | 26.7 | 37.6 | 24.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.28 | 6.32 | 16.1 | 3.02 | 2.92 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 749 | 710 | 637 | 619 | 628 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.68 | 0.657 | 3.08 | 1.79 | 0.566 |
| Long Term Notes Receivable | |||||
| Total Assets | 750 | 711 | 641 | 620 | 629 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 90.5 | 148 | 97.1 | 95.8 | 126 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 90.6 | 148 | 98.9 | 96.3 | 126 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 660 | 562 | 542 | 524 | 503 |
| Total Liabilities & Shareholders' Equity | 750 | 711 | 641 | 620 | 629 |
| Total Common Shares Outstanding |